Infectologia
OMS lança diretrizes de tratamento clínico para influenza.
24 Mar, 2022 | 12:36hComunicado de imprensa: WHO releases clinical management guidelines for influenza – World Health Organization
Relatório original: Guidelines for the clinical management of severe illness from influenza virus infections – World Health Organization
Estudo randomizado | Entre pacientes críticos com Covid-19, o tratamento com um agente antiplaquetário teve pouca propensão a melhorar os dias sem suporte de órgão em 21 dias.
24 Mar, 2022 | 12:33hEditorial: Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status – JAMA
Comentário: Aspirin may improve 3-month survival for patients critically ill with COVID-19 – Imperial College London
Comentários no Twitter
In this bayesian randomized clinical trial, among critically ill patients with #COVID19, there was a low likelihood that treatment with an antiplatelet agent provided improvement in organ support–free days within 21 days. https://t.co/CnyWoOTn3Q
— JAMA (@JAMA_current) March 22, 2022
Vacina de Oxford contra Covid se prepara para o ato final: salvar o resto do mundo.
24 Mar, 2022 | 12:32hOxford Covid jab gears up for final act: saving the rest of the world – The Guardian
Estudo de coorte | Complicações perinatais em indivíduos na Califórnia com ou sem infecções por SARS-CoV-2 durante a gestação.
24 Mar, 2022 | 12:29hComunicado de imprensa: Coronavirus may double severe complications in pregnancy – Kaiser Permanente
Comentário: COVID-19 in pregnancy tied to poor maternal outcomes, preterm birth, fetal death – CIDRAP
Estudo de coorte | Riscos e impactos do diabetes incidente na “long COVID”.
24 Mar, 2022 | 12:27hIncidência de complicações oculares em pacientes com candidíase disseminada e implicações para a prática de exames oculares de rotina.
24 Mar, 2022 | 11:58hNovas diretrizes da OMS sobre o tratamento da tuberculose em crianças e adolescentes.
23 Mar, 2022 | 12:10hConteúdo relacionado: RCT: In children with nonsevere, drug-susceptible tuberculosis, treatment for 4 months is noninferior to treatment for 6 months.
Revisão | Quando operar após infecção por SARS-CoV-2?
23 Mar, 2022 | 12:02hConteúdos relacionados:
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
BJS commission on surgery and perioperative care post-COVID-19.
ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.
Position statement: Perioperative management of post-COVID-19 surgical patients.
Prevenção e tratamento do resfriado comum: quais são as evidências?
23 Mar, 2022 | 11:58hPreventing and treating the common cold: what’s the evidence? – Evidently Cochrane
Comentário no Twitter
Preventing & treating the #CommonCold: what’s the evidence? https://t.co/kWHTwX1spb
Dr Lynda Ware looks at 14 possible interventions, including:
☀️ vitamin supplements,
💊 medicines,
🍯 home & herbal remedies
💉 vaccinesMight anything help & what are the possible risks? pic.twitter.com/ehpqEX8gwp
— Cochrane UK (@CochraneUK) March 21, 2022
Genotipagem rápida no local de atendimento para evitar a ototoxicidade induzida por aminoglicosídio na UTI neonatal.
23 Mar, 2022 | 11:27hEditorial: Genetic Testing in Newborns Moves From Rare to Routine Application
Comentário no Twitter
The MT-RNR1 m.1555A>G variant predisposes to profound aminoglycoside-induced ototoxicity
The MT-RNR1 POCT was able to genotype the m.1555A>G variant in 26 minutes. #IDTwitter #medtwitter #TwitteRx #MedEd #PIDTwitter https://t.co/BbkpNMiNHN— Antibiotic Steward Bassam Ghanem🆔🔥 (@ABsteward) March 21, 2022


